More Than Half of Patients with Vision-Threatening Condition Unaware They Have It

Joslin Diabetes Center investigators’ study finds discrepancies between participants’ eye health status and their self-reported eye health. Read more.
Read more on More Than Half of Patients with Vision-Threatening Condition Unaware They Have It

In Brief: Preventing Beta Cell Dysfunction

Researchers at Joslin Diabetes Center address that chronically high sugar levels that occur during the early development of diabetes can affect the ability of beta cells to produce insulin.
Read more on In Brief: Preventing Beta Cell Dysfunction

Important News from Joslin Diabetes Center 

Dana-Farber and BIDMC form cancer collaboration, including proposal to build a new, dedicated adult cancer hospital at current Joslin Diabetes Center site.
Read more on Important News from Joslin Diabetes Center 

Selected Spring 2023 Publications from Joslin Faculty

At Joslin, our researchers are making incredible discoveries that improve diabetes care and move us closer to a cure. Below are selected academic publications led by Joslin faculty issued in recent...
Read more on Selected Spring 2023 Publications from Joslin Faculty

Afternoon Exercise Linked with Greater Improvements in Blood Sugar Levels for Patients with Type 2 Diabetes

In an analysis of the Look AHEAD study, researchers found that participants who were physically active in the afternoon had greater reductions in blood sugar than those who were most active at other...
Read more on Afternoon Exercise Linked with Greater Improvements in Blood Sugar Levels for Patients with Type 2 Diabetes

Joslin and COVID-19 Vaccine(s)

Joslin and COVID-19 Vaccine(s)

Joslin does not have a supply of COVID-19 vaccine and therefore we are unable to offer it to patients. However, the vaccines are now widely available to anyone over the age of 6 months and both Joslin...
Read more on Joslin and COVID-19 Vaccine(s)

Phase 3 Trial Finds Oral Empagliflozin Provided Safe Glycemic Control in Children with Type 2 Diabetes

Joslin Diabetes Center researchers completed a phase 3 clinical trial of two different classes of oral agents for the treatment of type 2 diabetes in young people aged 10-17 years. Read about their findings.
Read more on Phase 3 Trial Finds Oral Empagliflozin Provided Safe Glycemic Control in Children with Type 2 Diabetes
Drs wearing masks

Joslin and COVID-19

Joslin and COVID-19

Joslin is committed to providing a safe environment for our staff and patients and therefore we have precautions in place to prevent the spread of infectious disease including: Masking: all patients...
Read more on Joslin and COVID-19

Joslin Diabetes Center Physicians Recognized in Boston Magazine’s 2023 ‘Top Doctors’

BOSTON – Boston Magazine has named 10 physicians from three medical specialties affiliated with Joslin Diabetes Center to its annual ‘Top Doctors’ guide. Drawing from a Castle Connolly Medical Ltd...
Read more on Joslin Diabetes Center Physicians Recognized in Boston Magazine’s 2023 ‘Top Doctors’

To make an adult care appointment, call 617-309-2400 or make an appointment online.